Now showing items 1-4 of 4
Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study
What is known and objectiveAlthough inappropriate use of digoxin has been described in various populations, a real-world evaluation of patterns of digoxin prescription has not been well studied in patients with atrial ...
Higher cancer antigen 125 level is associated with the presence of permanent atrial fibrillation in systolic heart failure patients
(ACTA CARDIOLOGICA, 2016)
Introduction Atrial fibrillation (AF) is a common arrhythmia in heart failure (HF). Recent studies have shown that serum cancer antigen-125 (CA-125) levels are elevated in HF, and high levels of CA-125 in HF patients with ...
ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)
(TURKISH SOC CARDIOLOGY, 2016)
Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF ...
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study
(LIPPINCOTT WILLIAMS & WILKINS, 2016)
This study aimed to investigate the potential misuse of novel oral anticoagulants (NOACs) and the physicians' adherence to current European guideline recommendations in real-world using a large dataset from Real-life ...